Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.56%62.631.0%$426.63m
AMGNAmgen, Inc. -1.61%237.601.3%$415.39m
BIIBBiogen, Inc. 0.59%287.191.4%$362.99m
ILMNIllumina, Inc. 1.11%328.333.5%$323.56m
VRTXVertex Pharmaceuticals, Inc. -0.78%233.991.9%$273.36m
REGNRegeneron Pharmaceuticals, Inc. -5.76%363.712.6%$217.27m
EXASEXACT Sciences Corp. -2.45%85.9024.0%$197.11m
ITCIIntra-Cellular Therapies, Inc. -3.12%25.439.0%$173.46m
ALXNAlexion Pharmaceuticals, Inc. -0.23%113.012.0%$173.06m
INCYIncyte Corp. -2.30%78.652.5%$135.12m
SRPTSarepta Therapeutics, Inc. -3.84%122.9914.6%$133.04m
AAgilent Technologies, Inc. -0.56%89.621.6%$120.06m
BMRNBioMarin Pharmaceutical, Inc. -0.82%87.554.3%$106.16m
BLUEbluebird bio, Inc. -2.26%95.8214.2%$95.27m
SGENSeattle Genetics, Inc. -0.30%108.676.1%$90.33m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.